v3.25.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (6,087,182) $ (4,244,708)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on investment 115,000
Gain on settlement of debt (4,904,081)
Stock-based compensation expense 924,894 974,602
Depreciation and amortization 883,622 631,544
Amortization of debt discount 1,319,121 1,858,655
Lease liability amortization (35,040) (128,274)
Changes in operating assets and liabilities    
Accounts receivable 277,992 (277,790)
Prepaid expenses and other current assets 29,467 61,737
Accounts payable and accrued liabilities 2,559,519 2,328,538
Deferred revenue 481,884 (669,582)
Interest payable 796,118 5,151,460
Deposit 9,611
Net Cash provided by Operating Activities 1,275,006 782,101
CASH FLOWS FROM INVESTING ACTIVITIES:    
Advance payment for acquisition (115,000) (1,500,000)
Purchase of property and equipment (185,523)
Net Cash used in Investing Activities (115,000) (1,685,523)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of convertible notes payable 290,000 1,067,631
Repayment of convertible notes payable (303,488) (438,059)
Proceeds from issuance of notes payable 1,689,868
Repayment of notes payable (865,746) (1,562,535)
Proceeds from related parties 288,406 422,935
Repayment to related parties (485,540) (193,560)
Net Cash (used in) provided by Financing Activities (1,076,368) 986,280
Net change in cash 83,638 82,858
Cash, beginning of period 84,570 1,712
Cash, end of period 168,208 84,570
Supplemental cash flow information    
Cash paid for interest 341,081 701,427
Cash paid for taxes
Non-cash transactions:    
Common stock issued for acquisition of subsidiary 2,000,000
Gain on settlement of debt 4,904,081
Settlement of convertible notes payable through issuance of common stock 47,518 357,592
Warrant issued in conjunction with debts 1,682,499
Common stock issued for conversion of Series A preferred stock $ 400